A new meta-analysis finds that combining an antidepressant with an antipsychotic medication is significantly more effective than other treatments for people with psychotic depression during the acute phase. Psychotic depression is a severe form of depression that includes symptoms like delusions or hallucinations. The analysis looked at data from several randomized controlled trials, though the exact number of participants was not reported.
The results showed that patients receiving combination therapy were nearly twice as likely to show clinical improvement (risk ratio 1.93). Specifically, they were about twice as likely to have a response (RR 2.03) and 78% more likely to achieve remission (RR 1.78) compared to those on non-combination treatments. These findings are consistent with current treatment guidelines.
However, the researchers caution that the number of available trials was limited and that different studies used different definitions of improvement, which can affect the reliability of the results. Safety information, such as side effects or how well patients tolerated the medications, was not reported in this analysis.
What this means for patients: If you or a loved one has psychotic depression, combination therapy may be a powerful option. But treatment decisions should always be made with a psychiatrist who can weigh the benefits and risks for your specific situation.
